These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 216156)

  • 1. [Means of producing rabbit immune antiherpes serum].
    Bikbulatov RM; Barinskiĭ IF
    Vopr Virusol; 1978; (5):625-6. PubMed ID: 216156
    [No Abstract]   [Full Text] [Related]  

  • 2. Reactions of immune sera against the nucleocapsid, envelope and whole herpes simplex virus type 1.
    Lesso J; Hána L; Matis J
    Acta Virol; 1976 Feb; 20(1):48-52. PubMed ID: 7940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus antigens on the surface of infected cells: binding and elution of ( 125 I)-labelled antivirus antibody.
    Rosenthal J; Hayashi K; Notkins AL
    J Gen Virol; 1973 Feb; 18(2):195-9. PubMed ID: 4348852
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation and efficacy of antiherpes type 1 and 2 subunit vaccines.
    Kavaklova L; Dundarov S; Andonov P; Bakalov B; Dundarova D; Brodvarova I
    Acta Virol; 1986 Sep; 30(5):402-10. PubMed ID: 2878588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of specific antibody to type 2 Herpes simplex virus among patients with carcinoma of the uterine cervix.
    Kawana T; Yoshino K; Kasamatsu T
    Gan; 1974 Oct; 65(5):439-45. PubMed ID: 4373302
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid micro-radioimmunoassay for the measurement of antiviral antibody.
    Rosenthal JD; Hayashi K; Notkins AL
    J Immunol; 1972 Jul; 109(1):171-3. PubMed ID: 4338438
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-herpetic vaccination by nasal route in rabbits].
    Schillinger G
    Ann Ocul (Paris); 1972 Aug; 205(8):941-51. PubMed ID: 4345394
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification of herpes simplex virus-specified major DNA-binding proteins and detection of antibodies to them in human and rabbit sera.
    Lehtinen M; Lehtinen T; Koivisto V; Paavonen J; Leinikki P
    Acta Virol; 1984 Nov; 28(6):449-56. PubMed ID: 6152122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The specificity of rabbit antisera to Herpesvirus hominis and its dependence on the dose of virus inoculated.
    Peutherer JF
    J Med Microbiol; 1970 May; 3(2):267-72. PubMed ID: 4318077
    [No Abstract]   [Full Text] [Related]  

  • 10. [Design of inactivated polyvalent antiherpes vaccines].
    Andonov P; Dundarov S; Bakalov B
    Vopr Virusol; 1979; (6):665-71. PubMed ID: 230648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of corneal inflammation due to Herpes simplex virus. I. Corneal hypersensitivity in the rabbit.
    Meyers RL; Pettit TH
    J Immunol; 1973 Oct; 111(4):1031-42. PubMed ID: 4353928
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterogeneity in the ability of rabbit 7S and 19S neutralizing antibodies to differentiate between intratypic antigenic variants of Herpes simplex virus.
    Hampar B; Mage MG; Keehn MA
    J Immunol; 1968 Aug; 101(2):256-61. PubMed ID: 4299203
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus.
    Hampar B; Notkins AL; Mage M; Keehn MA
    J Immunol; 1968 Mar; 100(3):586-93. PubMed ID: 4296105
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody and cell-mediated immunity to a DNA free herpes simplex subunit vaccine.
    Cappel R; de Cuyper F; de Braekeleer J
    Dev Biol Stand; 1979; 43():381-5. PubMed ID: 230114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A method of producing hyperactive sera against various respiratory viruses].
    Maĭorova LP; Noskov FS
    Vopr Virusol; 1966; 11(5):600-1. PubMed ID: 4302607
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparation and evaluation of anti-species and antiviral peroxidase conjugates.
    Zvonarev AYu ; Maltseva NN; Ebralidze LK
    Acta Virol; 1987 May; 31(3):218-25. PubMed ID: 2888285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains.
    Chang YJ; Jiang M; Lubinski JM; King RD; Friedman HM
    Vaccine; 2005 Sep; 23(38):4658-65. PubMed ID: 15936852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 2-deoxy-D-glucose on the binding of preimmune and immune sera to herpes simplex virus-infected cells as measured by quantitative immunofluorescence.
    Rajcáni J; Hulíková Z; Mucha V
    Acta Virol; 1979 Sep; 23(5):403-11. PubMed ID: 42300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic properties of formalin herpes antigen prepared from cell cultures.
    Benda R; Dbalý V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):237-49. PubMed ID: 4354219
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-idiotypic antibodies against antibodies to the herpes simplex virus and its early antigens].
    Kosiakova NP; Pavliuchenkova RP; Posevaia TA
    Vopr Virusol; 1991; 36(2):133-7. PubMed ID: 1652868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.